Recombinant DNA Advisory Committee - 10/7-8/91 
Arindam Bose, Pfizer Central Research 
Shannon Brownlee, U.S. News 
Joseph Chen, U.S. Department of Agriculture 
Yawen Chiang, Genetic Therapy, Inc. 
Robert Cooke, Newsday 
Carol Ezzell, Science News 
Oscar Fisher, Hood College 
Diane Fleming, Merck & Co. 
Jeffrey Fox, Science Writer 
Scott Freeman, University of Rochester Medical Center 
Diane Gershon, Nature Magazine 
T. Venkat Gopal, Otsuka Pharmaceuticals 
Jennifer Grace, Hood College 
Bill Greenwood, ABC News 
Marianne Grossman, University of Michigan 
Robin Herman, The Washington Post 
Yasuo Iriye, Otsuka Pharmaceuticals 
Bill Jenkins, ABC News 
Attila Kadar, Food and Drug Administration 
Michael Kaleko, Genetic Therapy, Inc. 
Richard Knudsen, Center for Disease Control 
Cheryl Ledford, Hood College 
Fred Ledley, Howard Hughes Medical Institute 
Karen Lim, Hood College 
Craig McCune, University of Rochester Cancer Center 
Michael McNeil, Center for Disease Control 
Robert Moen, Genetic Therapy, Inc. 
Lisa Morris, Genetic Therapy, Inc. 
Cheryl Osborne, Viagene Inc. 
Chris Plein, University of Missouri 
Cathleen Schmidt, Hood College 
Karen Schmidt, Science News 
Tomiko Shimada, AAI, Inc. 
Beth Smith, Hood College 
Sharon Smith, Hood College 
Sue Smith, Food and Drug Administration 
Clarence Styron, Monsanto Company 
Larry Thompson, The Washington Post 
Paul Tolstoshev, Genetic Therapy, Inc. 
George Wallrodt, Stenotech, Inc. 
David Wheeler, The Chronicle of Higher Education 
Lisa White, The Blue Sheet 
[ 8 ] 
Recombinant DNA Research, Volume 15 
